42 results
424B5
RNLX
Renalytix Plc
15 May 24
Prospectus supplement for primary offering
10:09am
, and, if not so available, may require us to delay, limit, curtail or discontinue our operations.
If we cannot continue to execute on our strategy to partner
8-K
EX-99.1
RNLX
Renalytix Plc
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
to discuss the financial results and key topics including business strategy, partnerships and regulatory and reimbursement processes, at 8:30 a.m. EDT
424B5
RNLX
Renalytix Plc
9 Apr 24
Prospectus supplement for primary offering
4:31pm
to delay, limit, curtail or discontinue our operations.
If we cannot continue to execute on our strategy to partner with healthcare systems to incorporate
8-K
EX-10.1
RNLX
Renalytix Plc
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
and agreed the allocation strategy with regard to the identity of the proposed Placees in accordance with the COB Rules and the Allocation Policy
8-K
EX-99.1
9s6fqlpf3
14 Nov 23
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
12:00am
10-Q
EX-10.2
kr8vwq5
14 Nov 23
Quarterly report
12:00am
10-Q
tc37v0
14 Nov 23
Quarterly report
12:00am
DEFR14A
kb07itfipod4o
13 Nov 23
Revised proxy
5:15pm
DEF 14A
0w1916yn8cllbzo9tez
13 Nov 23
Definitive proxy
9:22am
PRE 14A
5e5x0bx24k575ru8cj
3 Nov 23
Preliminary proxy
4:04pm
10-K/A
dt3ghm
5 Oct 23
Annual report (amended)
8:30pm
8-K
EX-99.1
9jlbm0vkr
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
10-K
gu8cp0nrbfjv
28 Sep 23
Annual report
6:18am
8-K
EX-99.1
89762u3 6j07k
8 Sep 23
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
4:04pm
6-K
5kjbf53xkgbkx3e
9 Jun 23
Current report (foreign)
7:01am
6-K
ubghxmxuz37 hdurtxj
30 Mar 23
Current report (foreign)
7:01am
6-K
i7mhewldu3uv6rw
30 Nov 22
Current report (foreign)
7:31am
6-K
EX-99.1
ixmaayz
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm